After the Ghidra toolkit drop

An Anon posted this image

And then Q posted this gift

Would you look a gift horse in the mouth?

If you use logic and discernment, then YES!

Verify first, and then trust.

If something comes all gift wrapped, like an app

Do you trust it?

Hell, NO!

You get Ghidra and check it out to make sure it does what it says.

What about all those apps that target patriots?

And so we return toBLOOD

Why does the gift have a Red Cross?

I think, because Q is telling us to check them out

Maybe they are not as trustworthy as they seem

Interesting that Canada does not use the Red Cross to handle blood donations

Instead, they have their own organization and it happens to use a very familiar form of logo.

Like the Good Doctor

Who happens to be an Autist

Is anyone using Ghidra to examine apps that target patriots?

Don't trust anything that you cannot verify.

Ghidra is a software GCMS (Gas Chromatograph/Mass Spectrometer)

You put samples of food, drugs, vaccine, into a GCMS

And it produces an analysis of what is actually in the sample

Does the food have BPA contamination?

Are the drugs doctored with Fentanyl?

Does the vaccine have large amounts of Aluminum?

Toolkits are not JUST for software!!!

=

The expanding role of mass spectrometry in the field of vaccine development

https://onlinelibrary.wiley.com/doi/full/10.1002/mas.21571

Abstract

Biological mass spectrometry has evolved as a core analytical technology in the last decade mainly because of its unparalleled ability to perform qualitative as well as quantitative profiling of enormously complex biological samples with high mass accuracy, sensitivity, selectivity and specificity. Mass spectrometry‐based techniques are also routinely used to assess glycosylation and other post‐translational modifications, disulfide bond linkage, and scrambling as well as for the detection of host cell protein contaminants in the field of biopharmaceuticals. The role of mass spectrometry in vaccine development has been very limited but is now expanding as the landscape of global vaccine development is shifting towards the development of recombinant vaccines. In this review, the role of mass spectrometry in vaccine development is presented, some of the ongoing efforts to develop vaccines for diseases with global unmet medical need are discussed and the regulatory challenges of implementing mass spectrometry techniques in a quality control laboratory setting are highlighted.